Clinical significance of CCN2/connective tissue growth factor in Behçet's disease patients.

Iman Hamed BassyouniWafaa Hob Sharkawy MohammedFatma M TahaRasha M El Refai

Published in: International journal of rheumatic diseases (2019)

Behçet's disease patients showed a significant increase of CCN2 levels, especially in the group of patients with major organ involvement. A significant reduction of these levels was found in patients who received steroids or cyclophosphamide. Larger studies with further investigations of the precise role of CCN2 in BD pathogenesis might lead to novel therapies for the clinical management of this disease.

Keyphrases

end stage renal disease
growth factor
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
patient reported outcomes
patient reported
case control